![Pathogens | Free Full-Text | Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation Pathogens | Free Full-Text | Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation](https://www.mdpi.com/pathogens/pathogens-10-00763/article_deploy/html/images/pathogens-10-00763-g005.png)
Pathogens | Free Full-Text | Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
![Cancers | Free Full-Text | Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies Cancers | Free Full-Text | Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies](https://www.mdpi.com/cancers/cancers-13-05189/article_deploy/html/images/cancers-13-05189-g001.png)
Cancers | Free Full-Text | Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
![Study of Epstein–Barr virus serological profile in Egyptian patients with Hashimoto's thyroiditis: A case-control study - ScienceDirect Study of Epstein–Barr virus serological profile in Egyptian patients with Hashimoto's thyroiditis: A case-control study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S221462372030017X-gr5.jpg)
Study of Epstein–Barr virus serological profile in Egyptian patients with Hashimoto's thyroiditis: A case-control study - ScienceDirect
![Antibody Responses to Epstein-Barr Virus Are Altered in the Pre-Clinical Period of Rheumatoid Arthritis - ACR Meeting Abstracts Antibody Responses to Epstein-Barr Virus Are Altered in the Pre-Clinical Period of Rheumatoid Arthritis - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2020/09/OCMVWLVW-907603-1-ANY-1-.jpg)
Antibody Responses to Epstein-Barr Virus Are Altered in the Pre-Clinical Period of Rheumatoid Arthritis - ACR Meeting Abstracts
![Antibodies | Free Full-Text | EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls Antibodies | Free Full-Text | EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls](https://www.mdpi.com/antibodies/antibodies-08-00035/article_deploy/html/images/antibodies-08-00035-g001.png)
Antibodies | Free Full-Text | EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls
![Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma | Gastric Cancer Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma | Gastric Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10120-021-01170-z/MediaObjects/10120_2021_1170_Fig1_HTML.png)
Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma | Gastric Cancer
![Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies | Journal of Neuroinflammation | Full Text Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies | Journal of Neuroinflammation | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12974-014-0188-1/MediaObjects/12974_2014_Article_188_Fig3_HTML.jpg)
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies | Journal of Neuroinflammation | Full Text
![Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis](https://www.frontiersin.org/files/Articles/665718/fimmu-12-665718-HTML/image_m/fimmu-12-665718-g001.jpg)
Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
![Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus - ScienceDirect Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S258990902100037X-gr2.jpg)
Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus - ScienceDirect
![Frontiers | High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk Frontiers | High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk](https://www.frontiersin.org/files/Articles/500363/fneur-10-01368-HTML/image_m/fneur-10-01368-g001.jpg)